Britannia Life Sciences Inc. (CSE:BLAB), a global product development platform for cosmetic and wellness products, is launching a consumer trial to test the efficacy of CBD oil as an active ingredient in the treatment of hair loss.
This hair growth initiative is aligned with Britannia's strategy of utilizing its resources and expertise to build a high-value intellectual property portfolio while growing the market for CBD by developing a broad range of new applications across a wide range of products, the company noted in a press statement.
